Ken Griffin Sensus Healthcare, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.93 - $7.05 $7,395 - $10,575	1,500 Added 250.0%	2,100 $12,000
Q2 2024 Aug 14, 2024	SELL	$3.14 - $6.42 $5,024 - $10,272	-1,600 Reduced 72.73%	600 $3,000
Q1 2024 May 15, 2024	BUY	$2.49 - $4.91 $5,478 - $10,802	2,200 New	2,200 $8,000
Q1 2023 May 15, 2023	SELL	$4.9 - $9.49 $109,760 - $212,576	-22,400 Reduced 76.19%	7,000 $36,000
Q4 2022 Feb 14, 2023	SELL	$5.91 - $14.28 $145,977 - $352,716	-24,700 Reduced 45.66%	29,400 $218,000
Q3 2022 Nov 14, 2022	BUY	$7.64 - $14.97 $121,476 - $238,023	15,900 Added 41.62%	54,100 $678,000

3.88M

24.9K

800

Ticker SRTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,556,000
Market Cap $129M
Description
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.